Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
Institute for Glycomics scientist Dr Ali Zaid has been recognised at the prestigious 2016 Queensland Young Tall Poppy Science Awards.
Innovative Australian scientist Dr Ali Zaid has joined Griffith University’s Institute for Glycomics to lead a project on Ross River...
Cars won’t be the only thing being housed in Griffith University’s new $23.3 million multistorey car park — it will...
Griffith University has once again cemented itself as a leader in appealing design and innovative sustainability features with the unveiling of its new $23.3 million multistorey car park.
Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Griffith University viral immunologist Professor Suresh Mahalingam has been appointed to a World Health Organization (WHO) advisory group tasked with combatting viruses like dengue and Zika.
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
